(R)-Methanandamide and Δ9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A
- 11 April 2003
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 466 (1-2) , 121-127
- https://doi.org/10.1016/s0014-2999(03)01491-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interactions between the CB1 receptor agonist Δ9-THC and the CB1 receptor antagonist SR-141716 in rats: Open-field revisitedPharmacology Biochemistry and Behavior, 2002
- Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of MiceBiochemical and Biophysical Research Communications, 2002
- Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluraminePharmacology Biochemistry and Behavior, 2002
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Effects of SR141716A on Ethanol and Sucrose Self‐AdministrationAlcohol, Clinical and Experimental Research, 2001
- Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout MiceJournal of Neurochemistry, 2000
- Δ9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replicationBehavioural Pharmacology, 2000
- Cannabis: Discrimination of “Internal Bliss”?Pharmacology Biochemistry and Behavior, 1999
- (R)-methanandamide, but not anadamide, substitutes for Δ–9-THC in a drug-discrimination procedure.Experimental and Clinical Psychopharmacology, 1997
- Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxicationNeuroscience & Biobehavioral Reviews, 1992